Verminderte Knochendichte und Veränderungen im ...

Literaturverzeichnis
154. Raison CL, Miller AH. When not enough is too much: the role of insufficient
glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J
Psychiatry. 2003;160:1554-65.
155. Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin
Invest. 2005;115:3318-25.
156. Reginster JY, Deroisy R, Paul I, Hansenne M, Ansseau M. Depressive
vulnerability is not an independent risk factor for osteoporosis in postmenopausal women.
Maturitas. 1999;33:133-7.
157. Renault PF, Hoofnagle JH, Park Y, et al. Psychiatric complications of long-term
interferon alfa therapy. Arch Intern Med. 1987;147:1577-80.
158. Rey JM, Morris-Yates A, Singh M, Andrews G, Stewart GW. Continuities
between psychiatric disorders in adolescents and personality disorders in young adults.
Am J Psychiatry. 1995;152:895-900.
159. Richards JB, Papaioannou A, Adachi JD, et al. Effect of selective serotonin
reuptake inhibitors on the risk of fracture. Arch Intern Med. 2007;167:188-94.
160. Rinne T, de Kloet ER, Wouters L, Goekoop JG, DeRijk RH, van den Brink W.
Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined
dexamethasone/corticotropin-releasing hormone challenge in female borderline
personality disorder subjects with a history of sustained childhood abuse. Biol Psychiatry.
2002;52:1102-12.
161. Rossi A, Marinangeli MG, Butti G, et al. Personality disorders in bipolar and
depressive disorders. J Affect Disord. 2001;65:3-8.
162. Rothschild L, Zimmerman M. Borderline personality disorder and age of onset in
major depression. J Personal Disord. 2002;16:189-99.
163. Roy A, Pickar D, Paul S, Doran A, Chrousos GP, Gold PW. CSF corticotropinreleasing
hormone in depressed patients and normal control subjects. Am J Psychiatry.
1987;144:641-5.
164. Rubin MR, Bilezikian JP. Clinical review 151: The role of parathyroid hormone in
the pathogenesis of glucocorticoid-induced osteoporosis: a re-examination of the
evidence. J Clin Endocrinol Metab. 2002;87:4033-41.
74